FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
216196NDAAGIOS PHARMS INC001PYRUKYNDTABLET;ORALEQ 5MG BASEMITAPIVAT SULFATE2022-02-17PrescriptionNo
002PYRUKYNDTABLET;ORALEQ 20MG BASEMITAPIVAT SULFATE2022-02-17PrescriptionNo
003PYRUKYNDTABLET;ORALEQ 50MG BASEMITAPIVAT SULFATE2022-02-17PrescriptionYes